San Diego, CA, 27 January, 2026: iXCells Biotechnologies (“iXCells”), a leading provider of human cell-based solutions and ...

Organoids are an important component of translational research, particularly for evaluating drug toxicity and tissue-specific responses.

REPROCELL today announced the commercial launch of StemEdit, its clinical gene editing services and new gene-edited iPSC product lines leveraging OpenCRISPR-1™, an AI-designed genome editing system ...

PRNewswire/ — International Health Dialogue (IHD) 2026 opened today in Hyderabad, bringing together clinicians, patient safety leaders, accreditation experts, and health system policymakers from India ...

A string of clinical and regulatory milestones in the December quarter highlighted growing momentum for ASX health stocks ...

Argano, the world's first and largest Global Specialist Consultancy exclusively focused on the design and delivery of High-Performance Business Operations with an AI-forward approach to transformation ...

Heart disease is one of the top killers in the United States and worldwide. With more than 5 millions heart failure cases per year in US, it is alarming that half of those patients cannot survive ...

Pricefx, a provider of AI-powered, cloud-native pricing software, today announced it has been named a Leader in the IDC MarketScape: Worldwide B2B Revenue and Profit Optimization Platforms 2025?2026 ...

The financial trajectory of the exosome therapy market is decoupling from the broader, slower-growing regenerative medicine ...

Prior to 2006, the scientific consensus was that cell differentiation was a one-way street: once mature, cells could not be returned to their initial embryonic-like state, having lost the potential to ...